Genmab A/S ADS (GMAB) Financials

Key financial figures for Genmab A/S ADS (Q3 2026).

Genmab A/S reported revenue of $1.19 billion for Q3 FY2026, up 16.1% from the same period a year earlier. Net income was $342.0 million, or $0.55 per share. Operating margin came to 37.15%, against 44.91% a year earlier. Free cash flow for the period was $509.0 million. Across the last 5 reported quarters, quarterly revenue has risen from $1.02 billion in Q3 FY2025 to $1.19 billion in Q3 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Genmab A/S are on the SentiSense financials page.

Revenue
$1.2B
Net Income
$342M
EPS
$0.56
Total Assets
$12.9B
Operating Cash Flow
$520M

Recent quarters

PeriodRevenueNet IncomeEPSOperating MarginFree Cash Flow
Q3 FY2026$1.2B$342M$0.5537.15%$509M
Q2 FY2026$1.2B$303M$0.4935.24%$48M
Q1 FY2026$899M$53M$0.0825.11%-$2M
Q4 FY2025$1.1B$31M$0.0522.97%$287M
Q3 FY2025$1.0B$401M$0.6544.91%$534M

Recent fiscal years

PeriodRevenueNet IncomeEPSOperating MarginFree Cash Flow
FY2025$3.7B$964M$1.5433.6%$1.1B
FY2024$21.5B$7.8B$12.1431.14%$7.6B
FY2023$16.5B$4.4B$6.6032.3%$7.0B

Frequently asked questions

What was Genmab A/S's revenue last quarter?

Genmab A/S reported revenue of $1.19 billion for Q3 FY2026, up 16.1% from the same period a year earlier.

Is Genmab A/S profitable?

Yes. Genmab A/S reported net income of $342.0 million for Q3 FY2026, a net margin of 28.81% on revenue.

How has Genmab A/S's margin trended?

Operating margin was 37.15% in Q3 FY2026, compared with 44.91% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.

How much free cash flow did Genmab A/S generate?

Genmab A/S generated free cash flow of $509.0 million in Q3 FY2026, after capital expenditure.

Full income statement, balance sheet and cash flow for Genmab A/S ADS on SentiSense, with up to forty quarters and twenty fiscal years of history.